5004052025-10-012025-12-315004052025-04-012025-12-315004052025-10-012025-12-31in-capmkt:OtherExpenses1Member5004052025-04-012025-12-31in-capmkt:OtherExpenses1Memberiso4217:INRiso4217:INRxbrli:shares500405SPLPETRONOTLISTEDINE663A01033SUPREME PETROCHEM LIMITEDMain BoardEquity2025-04-012026-03-312026-01-202026-01-09INRLakhsQuarterlyThird quarterSingle segmentThe Group operates in Styrenics and Allied Products which in the context of Ind AS-108 Operating Segments constitutes a single reportable business segment.2026-01-2015:30:002026-01-2017:30:00Not applicable2025-10-012025-12-31UnauditedConsolidated12809337000883560001289769300083055020002704640000256940002096740004197600027140700085593500012414828000482865000-71243000411622000785770002630700010488400003067380000000306738000-29240003038140003056900001048000302771000104300037608300021.631.63001.631.631. First Line of ABS project having 70,000 TPA capacity at Amdoshi, Dist. Raigad, Maharashtra, under license from M/s Versallis S.P.A. Italy, was successfully commissioned and production started from September, 2025. The ABS plant operated satisfactorily. However, operations were suspended in December 2025 due to malfunctioning of a critical production equipment. Necessary action is being taken in consultation with the engineering consultant, equipment supplier and technical collaborator to restore the operations. <BR> <BR> 2. The above Statement of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended December 31, 2025 ("Unaudited Financial Results") comprising of the financial results of the parent Company and its subsidiary Xmold Polymers Private Limited ("Xmold") (together known as Group) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" (IND AS-34) as prescribed under Section 133 of the Companies Act, 2013 ("the Act") read with relevant rules thereunder. <BR> <BR> 3. These Unaudited Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on January 20, 2026. The Statutory Auditors of the Company have carried out a Limited Review of the said unaudited financial results. These Financial Results are prepared and published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, as amended. <BR> <BR> 4. The Company acquired control on Xmold with effect from April 1, 2025, consequently, there are no corresponding figures for the consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2024 and the previous year ended March 31, 2025. <BR> <BR> 5. The Group operates in 'Styrenics and Allied Products' which, in the contexts of Ind AS-108 "Operating Segments", constitutes a single reportable business segment. <BR> <BR> 6. Finance cost significantly comprises of interest expense on lease pertaining to Ind AS 116-Leases. The Group continues to remain debt free. <BR> <BR> 7. On November 21, 2025, the Government of India notified new Labour Codes. The Group is in the process of evaluating the full impact of these labour codes. The Group has estimated and accounted for incremental liability on the basis of the best information currently available, consistent with the guidance provided by the Institute of Chartered Accountants of India. The incremental impact on the consolidated financial results consists of gratuity liability amounting to Rs. 533.43 Lakhs (Standalone - Rs. 529.93 lakhs) and compensation towards leave encashment Rs.179.00 Lakhs (Standalone - Rs.179.00 Lakhs) arises primarily due to change in "wage" definition. The Group continues to monitor the finalisation of Central/State Rules and clarifications from the Government related to provisions of the new Labour Codes and would provide appropriate accounting effect on the basis of such developments, as may be applicable to the Group. The same has been disclosed as an Exceptional Item in the Unaudited Financial Results. <BR> <BR> 8. The Company does not have any associates or joint ventures.2025-04-012025-12-31UnauditedConsolidated3800598400032790800038333892000255873240007355940000-5012040005631990001035050006415050002341535000360918040002242088000-712430002170845000445645000113224000558869000016119760000000161197600021040001614080000160684100051350001608959000512100037608300028.558.55008.558.55Other Expenses855935000Other Expenses23415350003908000-2808000-984000704000-29240002104000